Beijing GoBroad Hospital北京高博医院
International Hospital in Beijing, China
Beijing GoBroad Hospital is a leading private research-oriented hospital and flagship institution of the GoBroad Healthcare Group, established in 2017. Located in Changping Life Science Park, Beijing, the hospital officially opened in July 2023 and specializes in solid tumors, hematologic tumors, and brain science. It is renowned as one of China's top centers for CAR-T cell immunotherapy and hematopoietic stem cell transplantation (bone marrow transplant), treating patients with lymphoma, myeloma, leukemia, and other challenging hematologic cancers. The hospital integrates clinical research, precision diagnostics, and innovative cellular therapies, with more than half of its team dedicated to clinical innovation. For international patients from 12+ countries, the hospital operates a dedicated International Patient Service Center providing end-to-end support including medical visa guidance, airport transfers, multilingual coordination, and international insurance assistance, achieving a 95% patient satisfaction rate.
Overview — Beijing GoBroad Hospital
Scale
Research-oriented hospital with 500 planned beds including 100 early-stage research beds, covering 100,000 sqm
Total Beds
500
City
Beijing, Beijing
Departments
Leading Surgeries & Procedures
Beijing GoBroad Hospital is at the forefront of cellular therapy and transplant medicine. The hospital excels in CAR-T cell immunotherapy for relapsed/refractory B-cell lymphoma, achieving remarkable remission rates in patients who have failed conventional treatments. Its hematopoietic stem cell transplantation (HSCT) program, combining autologous transplant with CAR-T therapy, has demonstrated significantly improved progression-free survival for aggressive lymphomas and central nervous system lymphomas. The hospital also pioneers radionuclide therapy with four dedicated treatment wards serving 200+ patients annually, and performs advanced minimally invasive interventional oncology procedures for solid tumors including liver cancer and lung cancer.
Key Surgical Departments
The Hematology & Oncology Center is the hospital's flagship department, led by experts in CAR-T cell therapy and bone marrow transplantation, treating leukemia, lymphoma, myeloma, and thalassemia with cutting-edge immunotherapy protocols. The Solid Tumor Center provides comprehensive multidisciplinary care for gastrointestinal, thoracic, urologic, and melanoma cancers, integrating precision targeted therapy and clinical trials of innovative drugs. The Brain Science Department focuses on neurodegenerative diseases including Parkinson's disease, utilizing novel therapeutic approaches. The Clinical Research Center serves as a public service platform for clinical research in Beijing, having partnered with hundreds of innovative pharmaceutical companies to conduct numerous clinical trials.
Notable Physicians
Dr. Kai Hu (胡凯) is a leading hematologist specializing in CAR-T cell therapy and autologous stem cell transplantation for aggressive B-cell lymphoma and CNS lymphoma. His team has presented groundbreaking research at EBMT 2026 demonstrating superior outcomes with combined HSCT and CAR-T approaches. Dr. Lin Shen (沈琳) is a distinguished gastrointestinal oncologist whose team published landmark research in BMJ on camrelizumab combined with chemotherapy for gastric cancer maintenance therapy. Dr. Jun Guo (郭军) is a renowned expert in urologic oncology and melanoma, contributing "Chinese wisdom" to global clinical research in genitourinary cancers.
International Patient Services at Beijing GoBroad Hospital
- International Patient Service Center
- CAR-T Cell Immunotherapy
- Bone Marrow Transplant (HSCT)
- Precision Targeted Therapy
- Clinical Trials
- Medical Visa Guidance
- Airport Transfers
- Multilingual Coordination
- International Insurance Assistance
- Pre & Post-Arrival Support
Accepted Insurance
Contact Information
Mon-Fri 8:00AM-5:00PM
Languages Available
Share This Hospital
Last updated: 2026-05-06
Request a Consultation
Fill in the form below and our international patient coordinator will contact you within 24 hours.
